You may have noticed that many well-known research peptide companies have recently removed GLP-based compounds from their websites.
This change is not due to safety concerns and does not mean GLP research has been banned.
What’s happening instead is an increase in regulatory and patent-related pressure surrounding GLP compounds that are still tied to active pharmaceutical development. Because of this, many reputable research suppliers have chosen to:
- Reduce public visibility
- Remove GLP listings from open websites
- Shift distribution to more controlled or private channels
This is a compliance and optics decision, not a reflection of product quality or research validity.
What This Means for You
- GLP research itself is still ongoing
- Availability has become more limited
- Public listings are being reduced to protect suppliers
- Trusted sources are adapting, not disappearing
The landscape is changing, and transparency matters.
Reta – GLP-3 Availability Update
At this time, the only two remaining reputable research sources I currently list for Retatrutide (GLP-3) is Peptide Restore and Peptira.
These sources remain available because they’ve taken steps to:
- Tighten compliance
- Limit marketing exposure
- Maintain clearer separation between education and research access
As always, I only list sources I’m comfortable standing behind from a research quality and transparency standpoint.
Important Note
These sites exists for education and awareness only. Availability can change quickly, and the goal here is to keep you informed—not rushed.
If additional changes occur, I’ll update this page so you’re not left guessing.
KempCoreFitness 